BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31673890)

  • 1. Clear cell chondrosarcoma in Von Hippel-Lindau disease.
    Dreijerink KMA; van Leeuwaarde RS; Hackeng WM; Giles RH; de Leng WWJ; Jutte PC; Suurmeijer AJH; van Nesselrooij BPM; Brosens LAA
    Fam Cancer; 2020 Jan; 19(1):41-45. PubMed ID: 31673890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroperitoneal paraganglioma with loss of heterozygosity of the von Hippel-Lindau gene: a case report and review of the literature.
    Anno M; Izawa S; Fujioka Y; Matsuzawa K; Saito K; Hikita K; Makishima K; Nosaka K; Takenaka A; Usui T; Yamamoto K
    Endocr J; 2022 Sep; 69(9):1137-1147. PubMed ID: 35466127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Hippel-Lindau gene alterations in sporadic benign and malignant pheochromocytomas.
    Dannenberg H; De Krijger RR; van der Harst E; Abbou M; IJzendoorn Y; Komminoth P; Dinjens WN
    Int J Cancer; 2003 Jun; 105(2):190-5. PubMed ID: 12673678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parasympathetic paragangliomas are part of the Von Hippel-Lindau syndrome.
    Gaal J; van Nederveen FH; Erlic Z; Korpershoek E; Oldenburg R; Boedeker CC; Kontny U; Neumann HP; Dinjens WN; de Krijger RR
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4367-71. PubMed ID: 19808854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
    Lott ST; Chandler DS; Curley SA; Foster CJ; El-Naggar A; Frazier M; Strong LC; Lovell M; Killary AM
    Cancer Res; 2002 Apr; 62(7):1952-5. PubMed ID: 11929809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
    Kawahara N; Kume H; Ueki K; Mishima K; Sasaki T; Kirino T
    Neurology; 1999 Jul; 53(1):208-10. PubMed ID: 10408561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
    Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular-genetic diagnostics of von Hippel-Lindau syndrome (VHL) in Bulgaria: first complex mutation event in the VHL gene.
    Glushkova M; Dimova P; Yordanova I; Todorov T; Tourtourikov I; Mitev V; Todorova A
    Int J Neurosci; 2018 Feb; 128(2):117-124. PubMed ID: 28849724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].
    Su Y; Shen WD; Wang CC; Han WJ; Liu J; Hou ZH; Song ZG; Huang DL; Han DY; Yang SM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):913-8. PubMed ID: 24444636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
    Yoshida M; Yao M; Ishikawa I; Kishida T; Nagashima Y; Kondo K; Nakaigawa N; Hosaka M
    Genes Chromosomes Cancer; 2002 Dec; 35(4):359-64. PubMed ID: 12378530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
    Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
    Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
    Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
    Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of von Hippel-Lindau protein correlates with decreased apoptosis and high chondrosarcoma grade.
    Chen C; Zhou H; Liu X; Liu Z; Ma Q
    J Bone Joint Surg Am; 2011 Oct; 93(19):1833-40. PubMed ID: 22005870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression.
    Périgny M; Hammel P; Corcos O; Larochelle O; Giraud S; Richard S; Sauvanet A; Belghiti J; Ruszniewski P; Bedossa P; Couvelard A
    Am J Surg Pathol; 2009 May; 33(5):739-48. PubMed ID: 19238077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mutation at IVS1 + 5 of the von Hippel-Lindau gene resulting in intron retention in transcripts is not pathogenic in a patient with a tongue cancer?: case report.
    Asakawa T; Esumi M; Endo S; Kida A; Ikeda M
    BMC Med Genet; 2012 Mar; 13():23. PubMed ID: 22462637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel gene mutation in von Hippel-Lindau disease - a report of two cases.
    Wang J; Cao W; Wang Z; Zhu H
    BMC Med Genet; 2019 Dec; 20(1):194. PubMed ID: 31823746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
    Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
    Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.